Clin2
NCT06924359Likely a fitRecruiting

Eye scans and blood tests for early Alzheimer's detection

Alzheimer's Disease (AD)

Part of Brain & nervous system clinical trials.

This study uses special eye scans and blood tests to find early signs of Alzheimer's disease. It aims to detect the disease before memory loss becomes severe, so treatment can start sooner.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
50 years and older
Study type
Observational

Who can take part

  • You are 50 years old or older.
  • You have been told you have Alzheimer's disease, mild memory problems, or just feel your memory is slipping — or you have no memory concerns.
  • You do not have another brain condition (like Parkinson's or a stroke) that affects your memory.
  • You can complete a memory and thinking test (with help if needed).
  • You are willing to have a blood sample taken.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04575337Recruiting
Biomarker study to help detect Alzheimer’s early

This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.

Beijing, Beijing Municipality
NCT07254234Recruiting
Eye scans to detect Alzheimer's-related proteins

This study uses a special eye scan to look for abnormal protein deposits in the retina, which may be linked to Alzheimer's disease. It is for people who are generally healthy but have mild memory concerns or mild cognitive impairment.

Abu Dhabi
NCT07803055Recruiting
Blood test for early signs of Alzheimer's disease

This study looks at tiny particles in the blood that may show early signs of Alzheimer's disease. It aims to help with earlier diagnosis and monitoring, which could lead to better care and treatment opportunities.

Rome
NCT06561906Recruiting
Early Alzheimer's detection using scans, genetics and blood

This study uses brain scans, blood tests, and genetic information to find early signs of Alzheimer's disease before memory problems start. It aims to predict who might develop Alzheimer's in the future.

Nanjing, Jiangsu
NCT07521722Not yet recruiting
Blood tests for early Alzheimer's detection in diverse communities

This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.

Barcelona
NCT05614310Recruiting
Brain scan study to spot early Alzheimer’s

This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.

Aberdeen

Hear when a new Alzheimer's Disease (AD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.